US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

July 03, 2020 by Newsclick

Newsclick’s Prabir Purkayastha points out that countries must use the compulsory licence clause to make sure the drug is available to all. He also analyses how this might be a prelude to similar acts once a vaccine is available.

× To Subscribe